Geoffrey P. Judge - Nov 15, 2024 Form 4 Insider Report for Everi Holdings Inc. (EVRI)

Role
Director
Signature
/s/ Geoffrey P. Judge by Todd A. Valli, Attorney-in-Fact
Stock symbol
EVRI
Transactions as of
Nov 15, 2024
Transactions value $
-$213,920
Form type
4
Date filed
11/15/2024, 07:33 PM
Previous filing
May 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVRI Common Stock Options Exercise $124K +16K +17.47% $7.74 108K Nov 15, 2024 Direct F1
transaction EVRI Common Stock Sale -$214K -16K -14.87% $13.37 91.6K Nov 15, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVRI Stock Option Options Exercise -$124K -16K -80% $7.74 4K Nov 15, 2024 Common Stock 16K $7.74 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reflected in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on August 16, 2024 for options originally granted on April 22, 2015 that would have expired in approximately five months on April 22, 2025.
F2 The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at a price ranging from $13.36 to $13.42. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Represents an original option award to purchase 50,000 shares of the Company's common stock, which vested periodically over a period of four years following the date of grant of April 22, 2015.